ETF Sector

XPH

Market Tracker

$41.71
+0.52
(+1.26%)
7:00 pm
Next Earnings: (est.) n/a

  • XPH (Selected)

    SPDR Series Trust - SPDR S&P Pharmaceuticals ETF

XPH Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

XPH Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

XPH Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

XPH Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

XPH Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

XPH Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/16/2026 PUT $41.00 10 +5 +100.00%
08/15/2025 PUT $40.00 4 +3 +300.00%
08/15/2025 PUT $42.00 3 +3
08/15/2025 CALL $36.00 0 0
08/15/2025 CALL $37.00 1 0
08/15/2025 CALL $38.00 1 0
01/16/2026 PUT $40.00 0 0
01/16/2026 PUT $42.00 0 0
01/16/2026 PUT $43.00 1 0
01/16/2026 PUT $44.00 0 0
01/16/2026 PUT $45.00 0 0
01/16/2026 PUT $46.00 0 0

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

XPH News

  • Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows

    05/27 01:45 am

    Seeking Alpha

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    05/16 06:20 am

    Zacks Investment Research

    Read more

  • 5 Beaten-Down Top-Ranked ETFs to Buy for a Turnaround

    05/14 08:00 am

    Zacks Investment Research

    Read more

  • A Look at Pharma ETFs Post Q1 Earnings

    05/07 11:30 am

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    02/15 07:20 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    02/14 07:20 am

    Zacks Investment Research

    Read more

  • A Look at Pharma ETFs After Q4 Earnings

    02/12 01:59 pm

    Zacks Investment Research

    Read more

  • If Bernie Sanders is right about Big Pharma, why are the stocks doing so badly?

    02/10 07:52 am

    MarketWatch

    Read more

  • Pfizer: Paying Too Much To Boost Revenues

    01/06 06:10 am

    Seeking Alpha

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    12/15 07:20 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    12/14 07:20 am

    Zacks Investment Research

    Read more

  • Pharma ETFs in Focus Post Q3 Earnings

    11/08 12:10 pm

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    09/18 06:20 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    08/21 06:20 am

    Zacks Investment Research

    Read more

  • Pharma ETFs in Focus Post Q2 Earnings

    08/11 12:15 pm

    Zacks Investment Research

    Read more

  • Cautious on Big Tech & AI? Try These Value-Focused Sector ETFs

    08/09 01:00 pm

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    07/18 06:20 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    06/21 06:20 am

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    05/18 06:20 am

    Zacks Investment Research

    Read more

  • Pharma ETFs Gain Post Q1 Earnings

    05/09 11:15 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    04/21 06:20 am

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    03/15 06:20 am

    Zacks Investment Research

    Read more

  • Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval

    02/15 10:43 am

    MarketWatch

    Read more

  • A Look at Pharma ETFs Post Q4 Earnings

    02/08 11:05 am

    Zacks Investment Research

    Read more

  • Pfizer’s COVID revenues have dropped off along with attention to the pandemic

    01/31 02:16 pm

    MarketWatch

    Read more

  • What investors need to know about Pfizer's latest downgrade

    01/27 08:36 am

    MarketWatch

    Read more

  • Is pharma M&A making a comeback?

    01/13 08:22 am

    MarketWatch

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    01/13 07:20 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    01/12 07:20 am

    Zacks Investment Research

    Read more

  • As COVID vaccine and Paxlovid sales decline, analysts want to know what's next for Pfizer

    01/06 09:57 am

    MarketWatch

    Read more

  • Amgen to Buy Horizon Therapeutics: ETFs to Bet On

    12/13 12:10 pm

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    11/11 07:20 am

    Zacks Investment Research

    Read more

  • Pharma ETFs in Focus Post Q3 Earnings

    11/09 12:10 pm

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    11/09 07:20 am

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    09/08 06:20 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    09/06 06:20 am

    Zacks Investment Research

    Read more

  • Get ready for more merger mania in the pharma sector for the rest of the year

    08/11 07:30 am

    MarketWatch

    Read more

  • ETF Areas to Win/Lose on Falling Biden's Approval Ratings

    07/27 01:00 pm

    Zacks Investment Research

    Read more

  • Pharma & Biotech ETFs at One-Month High: Here's Why

    07/08 08:00 am

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    07/08 06:20 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    07/07 06:20 am

    Zacks Investment Research

    Read more

  • 2 ETFs to Watch for Outsized Volume on Dividend and Pharma

    06/28 10:05 am

    Zacks Investment Research

    Read more

  • Is It Too Late to Buy AbbVie Stock?

    05/17 11:23 am

    The Motley Fool

    Read more

  • Pharma ETFs in Focus Post Q1 Earnings

    05/12 11:15 am

    Zacks Investment Research

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    04/15 06:20 am

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    03/29 06:20 am

    Zacks Investment Research

    Read more

  • Solid Q4 Earnings Fail to Impress Pharma ETFs

    02/22 01:15 pm

    Zacks Investment Research

    Read more

  • Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

    01/27 07:20 am

    Zacks Investment Research

    Read more

  • Is It Too Late to Buy AbbVie Stock?

    12/14 11:30 am

    The Motley Fool

    Read more

  • Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

    12/07 07:20 am

    Zacks Investment Research

    Read more
👀

Follow the Whales in real-time.

Free Week Trial →

🎁

Take 50% OFF With Code:

Use Coupon →